Hexima Limited (ASX:HXL)
Australia
· Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
Oct 24, 2024, 12:56 PM AEST
Hexima Company Description
Hexima Limited does not have significant operations.
It focuses on exploration of transactions with third parties, which could enable the value of the company’s assets.
Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis.
Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.
Hexima Limited
| Country | Australia |
| Founded | 1997 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Geoffrey Kempler |
Contact Details
Address: C/-Acclime Carlton, Victoria 3053 Australia | |
| Phone | 61 3 9824 5254 |
| Website | hexima.com.au |
Stock Details
| Ticker Symbol | HXL |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000111932 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Geoffrey Paul Kempler B.Sc. | MD and Chairman |
| Helen Molloy | Financial Controller |
| Prof. Marilyn A. Anderson A.O., AO, B.Sc., BSc (Hons), FAA, FAICD, FT | Chief Science Officer |
| Dr. Neil Forrester | Vice President of Business Development |
| Dr. Nancy Sacco Ph.D. | Chief Development Officer |
| Leanne Ralph AAICD, ACIS, BBus | Company Secretary |